.STUDY EMPHASIZE.06 August 2024.
A big randomized measured trial along with cisgender women highlights the problems of faithfulness to a regular oral preexposure treatment regiment and shows that twice-yearly treatment of lenacapavir may keep helpful HIV prevention degrees over 6 months.